Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic

Kerstin Kaulich1, Britta Blaschke, Astrid Nümann

  • 1Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany.

Insights

Molecular analysis of pleomorphic xanthoastrocytoma (PXA) reveals distinct genetic alterations compared to diffuse gliomas. These findings may aid in the differential diagnosis of cerebral gliomas.

Area of Science:

  • Neuro-oncology
  • Molecular genetics
  • Cancer research

Background:

  • Pleomorphic xanthoastrocytoma (PXA) is a rare cerebral neoplasm affecting children and young adults.
  • Systematic molecular aberration studies in PXA are limited.
  • Understanding PXA molecular genetics is crucial for diagnosis and treatment.

Purpose of the Study:

  • To investigate molecular genetic alterations in 62 PXAs.
  • To compare genetic profiles of PXA with diffusely infiltrating astrocytic gliomas.
  • To identify potential molecular markers for PXA diagnosis.

Main Methods:

  • Analysis of 62 PXAs for mutations in TP53, CDKN2A, CDK4, MDM2, and EGFR.
  • Loss of heterozygosity (LOH) analysis on chromosomes 1, 9p, 10, 17, 19q, and 22q.
  • Investigation of gene inactivation on 9p21 in a subset of PXAs.

Main Results:

  • TP53 mutations found in only 5% of PXAs.
  • No amplification of CDK4, MDM2, or EGFR genes.
  • LOH observed on 9p in 14% and on 22q in one PXA.
  • No homozygous deletion, mutation, or hypermethylation of CDKN2A, p14ARF, or CDKN2B.

Conclusions:

  • PXAs exhibit distinct chromosomal and genetic aberrations compared to diffuse gliomas.
  • These genetic differences likely contribute to the more favorable clinical behavior of PXA.
  • Molecular findings may assist in the differential diagnosis of cerebral gliomas.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...